Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

SHE:002020 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	3,981	4,086	3,920	3,717	3,401	3,214
Other Revenue	72.73	72.73	78.89	62.81	65.06	44.25
Revenue	4,054	4,159	3,999	3,780	3,467	3,258
Revenue Growth (YoY)	-1.10%	3.99%	5.79%	9.04%	6.40%	-10.66%
Cost of Revenue	2,087	2,098	1,988	1,774	1,547	1,277
Gross Profit	1,967	2,061	2,011	2,006	1,920	1,981
Selling, General & Admin	857.42	916.47	994.61	984.94	970.72	1,178
Research & Development	372.29	383.34	400.79	367.04	334.14	257.91
Other Operating Expenses	48.65	33.52	30.09	36.19	26.57	28.02
Operating Expenses	1,290	1,346	1,432	1,392	1,342	1,462
Operating Income	676.61	714.56	579.08	613.8	577.8	519.31
Interest Expense	-5.73	-7.74	-7.31	-6.01	-4.97	-6
Interest & Investment Income	85.79	80.2	66.71	85.05	96.29	79.73
Currency Exchange Gain (Loss)	2.93	2.93	3.43	14.43	-3.84	-9.77
Other Non Operating Income (Expenses)	-4.2	-3.4	-0.97	-3.21	-7.19	-9.77
EBT Excluding Unusual Items	755.39	786.54	640.94	704.06	658.09	573.49
Gain (Loss) on Sale of Investments	-42.48	-42.37	24.44	10.15	7.23	131.49
Gain (Loss) on Sale of Assets	2.5	2.59	6.86	0.61	-0.48	-0.04
Asset Writedown	6.94	-0.07	-0.01	-0.07	-8.42	-0.51
Other Unusual Items	112.72	97.3	35.81	35.56	43.12	54.54
Pretax Income	835.08	843.98	708.04	750.32	699.54	758.98
Income Tax Expense	123.78	124.85	84.62	82.49	81.57	105.65
Earnings From Continuing Operations	711.3	719.13	623.42	667.82	617.96	653.33
Minority Interest in Earnings	-7.25	-7.16	-4.52	-5.57	-5.42	-0.26
Net Income	704.05	711.96	618.9	662.25	612.54	653.07
Net Income to Common	704.05	711.96	618.9	662.25	612.54	653.07
Net Income Growth	10.20%	15.04%	-6.55%	8.12%	-6.21%	25.50%
Shares Outstanding (Basic)	848	858	860	860	817	796
Shares Outstanding (Diluted)	848	858	860	860	817	796
Shares Change (YoY)	-1.82%	-0.21%	-0.06%	5.31%	2.55%	-6.90%
EPS (Basic)	0.83	0.83	0.72	0.77	0.75	0.82
EPS (Diluted)	0.83	0.83	0.72	0.77	0.75	0.82
EPS Growth	12.24%	15.28%	-6.49%	2.67%	-8.54%	34.80%
Free Cash Flow	259.23	475.52	273.32	340.2	-33.37	179.21
Free Cash Flow Per Share	0.31	0.55	0.32	0.40	-0.04	0.23
Dividend Per Share	0.350	0.350	0.300	0.300	0.300	0.292
Dividend Growth	16.67%	16.67%	-	-	2.84%	-
Gross Margin	48.52%	49.56%	50.30%	53.06%	55.39%	60.80%
Operating Margin	16.69%	17.18%	14.48%	16.24%	16.67%	15.94%
Profit Margin	17.37%	17.12%	15.48%	17.52%	17.67%	20.04%
Free Cash Flow Margin	6.40%	11.43%	6.83%	9.00%	-0.96%	5.50%
EBITDA	968.82	989.48	784.87	766.56	713.89	642.51
EBITDA Margin	23.90%	23.79%	19.63%	20.28%	20.59%	19.72%
D&A For EBITDA	292.21	274.93	205.79	152.76	136.09	123.2
EBIT	676.61	714.56	579.08	613.8	577.8	519.31
EBIT Margin	16.69%	17.18%	14.48%	16.24%	16.67%	15.94%
Effective Tax Rate	14.82%	14.79%	11.95%	10.99%	11.66%	13.92%
Revenue as Reported	4,054	4,159	3,999	3,780	3,467	3,258
Advertising Expenses	-	-	-	-	5.13	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.